Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment of rare co-occurrence of Epstein-Barr virus-driven post-transplant lymphoproliferative disorder and hemophagocytic lymphohistiocytosis after allogeneic stem cell transplantation.
Weber T, Wickenhauser C, Monecke A, Gläser C, Stadler M, Desole M, Ligeti K, Behrmann C, Müller-Tidow C, Müller LP. Weber T, et al. Among authors: monecke a. Transpl Infect Dis. 2014 Dec;16(6):988-92. doi: 10.1111/tid.12287. Epub 2014 Sep 1. Transpl Infect Dis. 2014. PMID: 25179757
Case Report: Graft Versus Tumor Effect After Non-Myeloablative Allogeneic Stem-Cell Transplantation in a Patient With Brentuximab-Vedotin Refractory Sezary Syndrome.
Franke GN, Dumann K, Jentzsch M, Monecke A, Doehring C, Nehring-Vucinic C, Schwind S, Niederwieser D, Platzbecker U, Ziemer M, Vucinic V. Franke GN, et al. Among authors: monecke a. Front Oncol. 2021 Dec 9;11:749691. doi: 10.3389/fonc.2021.749691. eCollection 2021. Front Oncol. 2021. PMID: 34956873 Free PMC article.
First-line treatment with R-CHOP or rituximab-bendamustine in patients with follicular lymphoma grade 3A-results of a retrospective analysis.
Pouyiourou M, Meyer A, Stroux A, Viardot A, La Rosée P, Maschmeyer G, Kämpfe D, Kahl C, Vucinic V, Monecke A, Hirt C, Weber T, Meissner J, Witzens-Harig M, Böttcher S, Schmalenberg H, Marks R, Prange-Krex G, Kroschinsky F, Hauf E, Keller U, Koch K, Klapper W, Herold M, Scholz CW; East German Study Group for Hematology and Oncology (OSHO). Pouyiourou M, et al. Among authors: monecke a. Ann Hematol. 2020 Dec;99(12):2821-2829. doi: 10.1007/s00277-020-04171-7. Epub 2020 Jul 30. Ann Hematol. 2020. PMID: 32734548
Extramedullary Clonal Hematopoiesis with Indeterminate Potential.
Ramdohr F, Monecke A, Jentzsch M, Zehrfeld T, Borte G, Schwind S, Franke GN, Metzeler KH, Platzbecker U, Vucinic V. Ramdohr F, et al. Among authors: monecke a. Clin Lymphoma Myeloma Leuk. 2021 Sep;21(9):e696-e698. doi: 10.1016/j.clml.2021.04.008. Epub 2021 Apr 16. Clin Lymphoma Myeloma Leuk. 2021. PMID: 34001457 Free article. No abstract available.
Case Report: Large Granular Lymphocyte Leukemia (LGLL)-A Case Series of Challenging Presentations.
Pflug N, Littauer A, Beverungen D, Sretenovic A, Wahnschaffe L, Braun T, Dechow A, Jungherz D, Otte M, Monecke A, Bach E, Franke GN, Schwind S, Jentzsch M, Platzbecker U, Herling M, Vucinic V. Pflug N, et al. Among authors: monecke a. Front Oncol. 2022 Jan 5;11:775313. doi: 10.3389/fonc.2021.775313. eCollection 2021. Front Oncol. 2022. PMID: 35070980 Free PMC article.
Vital Hepatic Lymphoma Residuum or Excessive Immune Response? Challenging Treatment Decisions in a Patient With Systemic Lupus Erythematosus and Liver-Dominant Diffuse Large B-Cell Lymphoma: Case Report.
Kurch L, Georgi TW, Monecke A, Seehofer D, Borte G, Sabri O, Kluge R, Heyn S, Pierer M, Platzbecker U, Kayser S. Kurch L, et al. Among authors: monecke a. Front Oncol. 2022 Jan 18;11:798757. doi: 10.3389/fonc.2021.798757. eCollection 2021. Front Oncol. 2022. PMID: 35117998 Free PMC article.
In cis TP53 and RAD51C pathogenic variants may predispose to sebaceous gland carcinomas.
Le Duc D, Hentschel J, Neuser S, Stiller M, Meier C, Jäger E, Abou Jamra R, Platzer K, Monecke A, Ziemer M, Markovic A, Bläker H, Lemke JR. Le Duc D, et al. Among authors: monecke a. Eur J Hum Genet. 2021 Mar;29(3):489-494. doi: 10.1038/s41431-020-00781-x. Epub 2020 Dec 15. Eur J Hum Genet. 2021. PMID: 33319852 Free PMC article.
Salvage Therapy With Polatuzumab Vedotin, Bendamustine, and Rituximab Prior to Allogeneic Hematopoietic Transplantation in Patients With Aggressive Lymphomas Relapsing After Therapy With Chimeric Antigen Receptor T-Cells-Report on Two Cases.
Gerhardt K, Jentzsch M, Georgi T, Sretenović A, Cross M, Bach E, Monecke A, Leiblein S, Hoffmann S, Todorović M, Bila J, Sabri O, Schwind S, Franke GN, Platzbecker U, Vučinić V. Gerhardt K, et al. Among authors: monecke a. Front Oncol. 2021 Sep 16;11:737645. doi: 10.3389/fonc.2021.737645. eCollection 2021. Front Oncol. 2021. PMID: 34604075 Free PMC article.
27 results